Italian drug manufacturer Recordati announced strong financial projections for 2026, with core profits expected to reach over $1 billion. The company's focus on rare disease treatments has driven significant growth and helped shield it from broader market pressures.
An Italian pharmaceutical company announced ambitious financial targets for 2026 on Tuesday, projecting core earnings between 995 million and 1.03 billion euros ($1.18-1.22 billion) following strong performance in its rare diseases division.
Recordati’s strategic shift toward specialized treatments for uncommon medical conditions has proven successful, with therapies targeting endocrine disorders leading the charge. This focus has helped protect the company from pricing challenges and currency fluctuations that have impacted the broader European drug market.
“There is excellent momentum in rare diseases, which continues to be a key driver of growth and value creation for the group,” Chief Executive Officer Rob Koremans said in a statement.
Looking ahead to 2026, the Milan-headquartered company anticipates net revenues ranging from 2.73 to 2.80 billion euros, though currency headwinds are expected to create roughly a 3.5% negative impact. Management also expects adjusted net income to fall between 655-685 million euros.
The pharmaceutical firm reported impressive 2025 results, with core earnings climbing 14.5% compared to the previous year, reaching 991.1 million euros and achieving a 37.8% margin on net revenue. Total revenue expanded 11.8% to 2.62 billion euros.
Adjusted net income increased 14.5% annually to 651.1 million euros. The rare diseases division showed particularly strong performance, surging 29.7% compared to 2024, or 16.6% when accounting for comparable business conditions.
Five Hurt in New York Church Blast, Including Pastor and Firefighters
CBS Blocks Colbert Interview Over FCC ‘Equal Time’ Rules Under Trump Administration
Fatal Multi-Vehicle Crash in Colorado Kills 4 in Dust Storm Conditions
18-Year-Old Arrested After Running Toward Capitol with Loaded Shotgun